(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

SWEDISH ORPHAN BIOVITRUM

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: Estados Unidos

Snapshot rápido

SWEDISH ORPHAN BIOVITRUM

ST13

US500000079086907

Classe

5, 10, 35, 42, 45

Pedido

79086907

Registro

4133606

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

77

Atualização mais recente

18/06/2023

Tipo de marca

Verbal

Classes Nice

5, 10, 35, 42, 45

Data de depósito

08/06/2010

Data de registro

01/05/2012

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

08/08/2022

Última transação

08/08/2022

Escritório responsável

United States Patent and Trademark Office

Código da situação

707

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

Stockholm, SE

Examinador

FATHY, DOMINIC

Unidade examinadora

L40

Titulares e representantes

Titulares

Swedish Orphan Biovitrum AB (publ)
Swedish Orphan Biovitrum AB (publ)

Representantes

Donna J. Bunton NIXON & VANDERHYE P.C.

Classificação técnica

Classes Nice

Classe 5Classe 10Classe 35Classe 42Classe 45

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations in the field of human medicine for the prevention and treatment of hematological diseasesintestinal fat malabsorption diseasesinflammatory diseasesrheumatoid arthritiscancer* and * inherited metabolic diseases and cystic fibrosisall of the foregoing excluding vitamin and mineral preparations and vitaminized tonic drinks for medical purposes ; diagnostic preparations for medical usechemical reagents for medical use

Classe 10

Surgical instruments and apparatus; medical apparatus and instruments for use in general surgery; medical apparatus and instrumentsmedical apparatus for introducing pharmaceutical preparations into the human body and facilitating the inhalation of pharmaceutical preparations; testing apparatus for medical purposes for testing for the presence of drugs; and medical infusion and injection devices for administering drugs

Classe 35

Retail distributorship services in the field of pharmaceuticalsmedical preparationsvaccinesnatural remediesdiagnostics and medical devices

Classe 42

Medical research; biological and chemical research; research and development of new medicines and medical preparations; medical and chemical laboratories; scientific research and industrial research in the field of medicines

Classe 45

Licensing within the field of medicines; licensing of intellectual property

Publicações

Histórico de despachos e eventos da marca no USPTO.

77 publicações encontradas

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

18/06/2023

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

22/05/2023

INPC

INVALIDATION PROCESSED

22/05/2023

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

08/04/2023

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

08/08/2022

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

08/08/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/08/2022

ES71

TEAS SECTION 71 RECEIVED

25/02/2022

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

01/05/2021

RNWL

INTERNATIONAL REGISTRATION RENEWED

25/06/2020

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

28/02/2020

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

21/01/2020

INPC

INVALIDATION PROCESSED

21/01/2020

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

26/12/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

20/12/2019

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

07/08/2019

PRA7

REGISTERED - SEC. 7 REQUEST ABANDONED

07/08/2019

CORV

REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD

07/08/2019

ES7R

TEAS SECTION 7 REQUEST RECEIVED

25/03/2019

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

20/12/2018

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

20/12/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

28/11/2018

ES75

TEAS SECTION 71 & 15 RECEIVED

31/10/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

31/10/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

31/10/2018

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

01/05/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

31/03/2016

GPNX

NOTIFICATION PROCESSED BY IB

17/11/2012

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

17/08/2012

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/08/2012

FIMP

FINAL DISPOSITION PROCESSED

01/08/2012

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/08/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

01/05/2012

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

23/04/2012

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

13/03/2012

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

07/03/2012

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

14/02/2012

PUBO

PUBLISHED FOR OPPOSITION

14/02/2012

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

25/01/2012

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

25/01/2012

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

25/01/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/01/2012

ALIE

ASSIGNED TO LIE

11/01/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

20/12/2011

XAEC

EXAMINER'S AMENDMENT ENTERED

20/12/2011

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

20/12/2011

GNEA

EXAMINERS AMENDMENT E-MAILED

20/12/2011

CNEA

EXAMINERS AMENDMENT -WRITTEN

20/12/2011

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

28/11/2011

GNFR

FINAL REFUSAL E-MAILED

28/11/2011

CNFR

FINAL REFUSAL WRITTEN

28/11/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/11/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/11/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/11/2011

ATRV

ATTORNEY REVIEW COMPLETED

17/10/2011

LIMS

LIMITATION OF GOODS/SERVICES FROM IB ENTERED

17/10/2011

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

08/10/2011

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

05/08/2011

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/05/2011

GNRT

NON-FINAL ACTION E-MAILED

06/05/2011

CNRT

NON-FINAL ACTION WRITTEN

06/05/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

19/04/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/04/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

18/04/2011

PETG

PETITION TO REVIVE-GRANTED

18/04/2011

PROA

TEAS PETITION TO REVIVE RECEIVED

18/04/2011

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

18/04/2011

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

18/04/2011

RFNT

REFUSAL PROCESSED BY IB

10/11/2010

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

15/10/2010

RFRR

REFUSAL PROCESSED BY MPU

15/10/2010

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

15/10/2010

CNRT

NON-FINAL ACTION WRITTEN

14/10/2010

MAFR

APPLICATION FILING RECEIPT MAILED

12/10/2010

DOCK

ASSIGNED TO EXAMINER

08/10/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/10/2010

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/10/2010

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace SWEDISH ORPHAN BIOVITRUM ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.